Copyright
©The Author(s) 2005.
World J Gastroenterol. Sep 14, 2005; 11(34): 5283-5288
Published online Sep 14, 2005. doi: 10.3748/wjg.v11.i34.5283
Published online Sep 14, 2005. doi: 10.3748/wjg.v11.i34.5283
Reactivation pattern | Outcome | Cause of death | Type of DLR | Ratio of A/G ratio | Ratio of INR of PT |
A | Died | Hepatic failure | H | 0.62 | 3.88 |
A | Died | Hepatic failure | H | 1 | 1.27 |
A | Died | Cancer progression | N | 0.86 | NA |
A | Died | Cancer progression | N | 0.6 | 1.38 |
B | Alive | NA | N | NA | NA |
B | Died | Hepatic failure/cancer progression | H | NA | 1.36 |
- Citation: Su WP, Wen CC, Hsiung CA, Su IJ, Cheng AL, Chang MC, Tsao CJ, Kao WY, Uen WC, Hsu C, Hsu CH, Lu YS, Tien HF, Chao TY, Chen LT, Whang-Peng J, Chen PJ. Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patients. World J Gastroenterol 2005; 11(34): 5283-5288
- URL: https://www.wjgnet.com/1007-9327/full/v11/i34/5283.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i34.5283